Adjunctive Sitagliptin Therapy in Postoperative Cardiac Surgery Patients: A Pilot Study

Table 2

Study endpoints.

Endpoint	Sitagliptin; (𝑛=30)	Placebo; (𝑛=32)	𝑃 value
Mean blood glucose control (mg/dL)
Overall 4-day study period	147.29 ± 4.79	153.0 ± 4.61	0.388
SD no. 1	160.5 ± 33.0	150.5 ± 28.5
SD no. 2	163.1 ± 37.9	164.3 ± 33.9
SD no. 3	137.4 ± 25.1	149.7 ± 30.6
SD no. 4	128.2 ± 21.7	147.7 ± 34.5

SD: study day.